Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Choosing the Right Diagnostic Pathway in Biopsy-Naive Patients With Suspected Prostate Cancer

Choosing the Right Diagnostic Pathway in Biopsy-Naive Patients With Suspected Prostate Cancer Research Original Investigation Comparison of Multiparametric MRI-Targeted Biopsy With Systematic Transrectal Ultrasonography–Guided Biopsy multiparametric MR imaging of the prostate. study. Lancet. 2017;389(10071):815-822. imaging and recommendations for use. Eur Urol. Radiology. 2018;286(1):186-195. doi:10.1148/radiol. doi:10.1016/S0140-6736(16)32401-1 2016;69(1):41-49. doi:10.1016/j.eururo.2015.08.038 18. Rouvière O, Puech P, Renard-Penna R, et al; 24. Haffner J, Lemaitre L, Puech P, et al. Role of 12. Klotz L, Loblaw A, Sugar L, et al. Active MRI-FIRST Investigators. Use of prostate systematic magnetic resonance imaging before initial biopsy: Surveillance Magnetic Resonance Imaging Study and targeted biopsy on the basis of multiparametric comparison of magnetic resonance (ASIST): results of a randomized multicenter MRI in biopsy-naive patients (MRI-FIRST): imaging-targeted and systematic biopsy for prospective trial. Eur Urol. 2019;75(2):300-309. a prospective, multicentre, paired diagnostic study. significant prostate cancer detection. BJU Int. 2011; doi:10.1016/j.eururo.2018.06.025 Lancet Oncol. 2019;20(1):100-109. doi:10.1016/ 108(8 Pt 2):E171-E178. doi:10.1111/j.1464-410X.2011. S1470-2045(18)30569-2 10112.x 13. Klotz L, Pond G, Loblaw A, et al. Randomized study of systematic biopsy versus magnetic 19. van der Leest M, Cornel E, Israël B, et al. 25. Kasivisvanathan V, Dufour R, Moore CM, et al. resonance imaging and targeted and systematic Head-to-head comparison of transrectal Transperineal magnetic resonance image targeted biopsy in men on active surveillance (ASIST): 2-year ultrasound-guided http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

Choosing the Right Diagnostic Pathway in Biopsy-Naive Patients With Suspected Prostate Cancer

Rouvière, Olivier
JAMA Oncology , Volume 7 (4) – Apr 4, 2021
Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/choosing-the-right-diagnostic-pathway-in-biopsy-naive-patients-with-aiRA1Kjv4c
Publisher
American Medical Association
Copyright
Copyright 2021 American Medical Association. All Rights Reserved.
ISSN
2374-2437
eISSN
2374-2445
DOI
10.1001/jamaoncol.2020.7578
Publisher site
See Article on Publisher Site

Abstract

Research Original Investigation Comparison of Multiparametric MRI-Targeted Biopsy With Systematic Transrectal Ultrasonography–Guided Biopsy multiparametric MR imaging of the prostate. study. Lancet. 2017;389(10071):815-822. imaging and recommendations for use. Eur Urol. Radiology. 2018;286(1):186-195. doi:10.1148/radiol. doi:10.1016/S0140-6736(16)32401-1 2016;69(1):41-49. doi:10.1016/j.eururo.2015.08.038 18. Rouvière O, Puech P, Renard-Penna R, et al; 24. Haffner J, Lemaitre L, Puech P, et al. Role of 12. Klotz L, Loblaw A, Sugar L, et al. Active MRI-FIRST Investigators. Use of prostate systematic magnetic resonance imaging before initial biopsy: Surveillance Magnetic Resonance Imaging Study and targeted biopsy on the basis of multiparametric comparison of magnetic resonance (ASIST): results of a randomized multicenter MRI in biopsy-naive patients (MRI-FIRST): imaging-targeted and systematic biopsy for prospective trial. Eur Urol. 2019;75(2):300-309. a prospective, multicentre, paired diagnostic study. significant prostate cancer detection. BJU Int. 2011; doi:10.1016/j.eururo.2018.06.025 Lancet Oncol. 2019;20(1):100-109. doi:10.1016/ 108(8 Pt 2):E171-E178. doi:10.1111/j.1464-410X.2011. S1470-2045(18)30569-2 10112.x 13. Klotz L, Pond G, Loblaw A, et al. Randomized study of systematic biopsy versus magnetic 19. van der Leest M, Cornel E, Israël B, et al. 25. Kasivisvanathan V, Dufour R, Moore CM, et al. resonance imaging and targeted and systematic Head-to-head comparison of transrectal Transperineal magnetic resonance image targeted biopsy in men on active surveillance (ASIST): 2-year ultrasound-guided

Journal

JAMA Oncology – American Medical Association

Published: Apr 4, 2021

References

  • MRI-targeted or standard biopsy for prostate-cancer diagnosis
    Kasivisvanathan, V; Rannikko, AS; Borghi, M
  • Comparison of multiparametric magnetic resonance imaging–targeted biopsy with systematic transrectal ultrasonography biopsy for biopsy-naive men at risk for prostate cancer: a phase 3 randomized clinical trial
    Klotz, L; Chin, J; Black, PC
  • Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study
    Rouvière, O; Puech, P; Renard-Penna, R
  • Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-naïve men with elevated prostate-specific antigen: a large prospective multicenter clinical study
    van der Leest, M; Cornel, E; Israël, B
  • Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer
    Drost, FH; Osses, DF; Nieboer, D
  • Molecular hallmarks of multiparametric magnetic resonance imaging visibility in prostate cancer
    Houlahan, KE; Salmasi, A; Sadun, TY
  • The role of ipsilateral and contralateral transrectal ultrasound-guided systematic prostate biopsy in men with unilateral magnetic resonance imaging lesion undergoing magnetic resonance imaging-ultrasound fusion-targeted prostate biopsy
    Bryk, DJ; Llukani, E; Taneja, SS; Rosenkrantz, AB; Huang, WC; Lepor, H
  • Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation
    Schoots, IG; Padhani, AR